Effect of beta blockers in acute and chronic coronary syndromes without reduced ejection fraction: a landmark analysis from the REBOOT trial
Xavier Rosselló, José A. Barrabés, Massimo Piepoli, Alberto Domínguez-Rodríguez et autres
AIMS: Current guidelines recommend beta-blocker therapy after myocardial infarction (MI) regardless of left ventricular ejection fraction (LVEF). However, recent trials question their benefit in patients with preserved LVEF. No study has yet compared beta-blocker effects during the acute coronary syndrome (ACS) phase …
es, it, gb, us (code pays fourni par la source)
6 citations
European Heart Journal - Cardiovascular Pharmacotherapy